Derek E. Smith
University of Colorado Denver
31 Papers
31 Citations
Derek E. Smith is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Medicine & Lung cancer. The author has an hindex of 13, co-authored 31 publications. Previous affiliations of Derek E. Smith include Anschutz Medical Campus & Colorado School of Public Health.
Chat about Author
Papers
Ecology under lake ice
Stephanie E. Hampton,Aaron W. E. Galloway,Stephen M. Powers,Ted Ozersky,Kara H. Woo,Ryan D. Batt,Stephanie G. Labou,Catherine M. O'Reilly,Sapna Sharma,Noah R. Lottig,Emily H. Stanley,Rebecca L. North,Jason D. Stockwell,Rita Adrian,Gesa A. Weyhenmeyer,Lauri Arvola,Helen M. Baulch,Isabella Bertani,Larry L. Bowman,Cayelan C. Carey,Jordi Catalan,William Colom-Montero,Leah M. Domine,Marisol Felip,Ignacio Granados,Corinna Gries,Hans-Peter Grossart,Hans-Peter Grossart,Juta Haberman,Marina Haldna,Brian Hayden,Scott N. Higgins,Jeffrey C. Jolley,Kimmo K. Kahilainen,Enn Kaup,Michael J. Kehoe,Sally Macintyre,Anson W. Mackay,Heather L. Mariash,Robert Michael L. McKay,Brigitte Nixdorf,Peeter Nõges,Tiina Nõges,Michelle E. Palmer,Donald C. Pierson,David M. Post,Matthew J. Pruett,Milla Rautio,Jordan S. Read,Sarah Roberts,Jacqueline Rücker,Steven Sadro,Eugene A. Silow,Derek E. Smith,Robert W. Sterner,George E. A. Swann,Maxim A. Timofeyev,Manuel Toro,Michael R. Twiss,Richard J. Vogt,Susan B. Watson,Erika J. Whiteford,Marguerite A. Xenopoulos +62 more
TL;DR: This is the first global quantitative synthesis on under-ice lake ecology, including 36 abiotic and biotic variables from 42 research groups and 101 lakes, examining seasonal differences and connections as well as how seasonal differences vary with geophysical factors.
The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib.
Tejas Patil,Derek E. Smith,Paul A. Bunn,Dara L. Aisner,Anh T. Le,Mark Hancock,William T. Purcell,Daniel W. Bowles,D. Ross Camidge,Robert C. Doebele +9 more
TL;DR: The CNS is a common first site of progression in ROS1‐positive patients who are taking crizotinib, and the importance of developing CNS‐penetrant tyrosine kinase inhibitors for patients with ROS1-positive NSCLC is reinforced.
173
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study.
Chad G. Rusthoven,Masaaki Yamamoto,Denise Bernhardt,Derek E. Smith,Dexiang Gao,Toru Serizawa,Shoji Yomo,Hitoshi Aiyama,Yoshinori Higuchi,Takashi Shuto,Atsuya Akabane,Yasunori Sato,Ajay Niranjan,Andrew Faramand,L. Dade Lunsford,James McInerney,Leonard Tuanquin,Brad E. Zacharia,Veronica Chiang,Charu Singh,James B. Yu,Steve Braunstein,David Mathieu,Charles J Touchette,Cheng-Chia Lee,Huai-Che Yang,Ayal A. Aizer,Daniel N. Cagney,Michael D. Chan,Douglas Kondziolka,Kenneth E. Bernstein,Joshua S. Silverman,Inga S. Grills,Zaid A. Siddiqui,Justin C. Yuan,Jason P. Sheehan,Diogo Cordeiro,Kename Nosaki,Takahashi Seto,Christopher P Deibert,Vivek Verma,Samuel E. Day,Lia M. Halasz,Ronald E Warnick,Daniel M. Trifiletti,Joshua D. Palmer,Albert Attia,Benjamin Li,Christopher P. Cifarelli,Paul D. Brown,John A. Vargo,John A. Vargo,Stephanie E. Combs,Kerstin A. Kessel,Stefan Rieken,Samir Patel,Matthias Guckenberger,Nicolaus Andratschke,Brian D. Kavanagh,Tyler P. Robin +59 more
TL;DR: Results of this study suggest that the primary trade-offs associated with SRS without WBRT, including a shorter TTCP without a decrease in overall survival, are similar to those observed in settings in which SRS is already established.
Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non-Small Cell Lung Cancer.
Jose M. Pacheco,Dexiang Gao,Dexiang Gao,Derek E. Smith,Derek E. Smith,Thomas Purcell,Mark Hancock,Paul A. Bunn,Tyler P. Robin,Arthur K. Liu,Sana D. Karam,Laurie E. Gaspar,Brian D. Kavanagh,Chad G. Rusthoven,Dara L. Aisner,Robert C. Doebele,D. Ross Camidge +16 more
TL;DR: Patients with stage IV ALK‐positive NSCLC can have prolonged OS, and each additional month of pemetrexed‐based therapy was associated with a 7% relative decrease in risk of death.
139
Assessment of a Machine Learning Model Applied to Harmonized Electronic Health Record Data for the Prediction of Incident Atrial Fibrillation
Premanand Tiwari,Kathryn L. Colborn,Derek E. Smith,Fuyong Xing,Debashis Ghosh,Michael A. Rosenberg +5 more
- 03 Jan 2020
TL;DR: In this article, a machine learning approach was applied to electronic health record data that have been harmonized to the Observational Medical Outcomes Partnership Common Data Model for identifying risk of atrial fibrillation (AF).